Profile of:

Bassel El-Zorkany


Professor and head of rheumatology dept., Cairo university General secretary of the Egyptian Society for Rheumatic disease (ESRd). Board member of Egyptian back pain society. ORCID ID: https://orcid.org/0000-0003-2704-9712 Life-long interest in spondyloarthritis, since my MD thesis titled "pattern of spondyloarthritis among Egyptians", that was successfully criticized and passed in 1993. Most recent SpA-related manuscripts that were co-authored in last 5 years López-Medina C, Molto A, Sieper J, .... Elzorkany B. ... et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 2021;7:e001450. doi:10.1136/rmdopen-2020-001450 El Zorkany B. et al. The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management. Int J Rheum Dis. 2020;23:1574–1580. DOI: 10.1111/1756-185X.13961 Kiltz U, …. Elzorkany B, et al. Measurement properties of the ASAS health index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis., 2018; 77:1311–1317. Elzorkany B et al., Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries. Clin Rheumatol; 2018. doi.org/10.1007/s10067-018-3982-9 Molto A., … Elzorkany B, et al. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis. 2018; 77:124-7 Kiltz U, …. Elzorkany B, et al. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. RMD Open 2016; doi:10.1136/rmdopen-2016-000311. Al-Emadi S, … Elzorkany B, et al., Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East. Clin Rheumatol. 2016; 35(1): 25-31. Molto A. … Elzorkany B, et al. Prevalence of comorbidities and evaluation of their screening in Spondyloarthritis: Results of the international cross-sectional ASAS-COMOSpA Study. Ann Rheum Dis 2016; 75(6):1016-1023.

Full name: Bassel El-Zorkany

Current country: Egypt

Membership level: Full

Type of membership: Member

Number of publications: 20

The rheumatology workforce in the Arab countries: current status, challenges, opportunities, and future needs from an ArLAR cross‑sectional survey (2023)
https://pubmed.ncbi.nlm.nih.gov/37624401/

What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/35489171/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Treat-to-Target in Axial Spondyloarthritis: Are we there yet? (2022)
https://pubmed.ncbi.nlm.nih.gov/36127927/

Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines (2022)
https://pubmed.ncbi.nlm.nih.gov/34993578/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246/

The ASAS-OMERACT Core Domain Set for Axial Spondyloarthirtis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34615639/

Root Joint Involvement in Spondyloarthritis: A Post-hoc Analysis from the International ASAS-PerSpA Study (2021)
https://pubmed.ncbi.nlm.nih.gov/33905488/

The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management. (2020)
https://pubmed.ncbi.nlm.nih.gov/32931147/

Measurement properties of the ASAS health index: results of a global study in patients with axial and peripheral spondyloarthritis. (2018)
https://pubmed.ncbi.nlm.nih.gov/29858176/

Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries. (2018)
https://pubmed.ncbi.nlm.nih.gov/29411181/

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. (2017)
https://pubmed.ncbi.nlm.nih.gov/29038299/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/

Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East. (2016)
https://pubmed.ncbi.nlm.nih.gov/26304021/

Prevalence of comorbidities and evaluation of their screening in Spondyloarthritis: Results of the international cross-sectional ASAS-COMOSpA Study (2015)
https://pubmed.ncbi.nlm.nih.gov/26489703/

Early Diagnosis and Treatment of Ankylosing Spondylitis in Africa and the Middle East (2012)
https://pubmed.ncbi.nlm.nih.gov/22903740/

The practical value of biologics registries in Africa and Middle East: Challenges and opportunities (2012)
https://pubmed.ncbi.nlm.nih.gov/22228237/